ZA955153B - Controlled release aqueous emulsion - Google Patents

Controlled release aqueous emulsion

Info

Publication number
ZA955153B
ZA955153B ZA955153A ZA955153A ZA955153B ZA 955153 B ZA955153 B ZA 955153B ZA 955153 A ZA955153 A ZA 955153A ZA 955153 A ZA955153 A ZA 955153A ZA 955153 B ZA955153 B ZA 955153B
Authority
ZA
South Africa
Prior art keywords
oil
weight percent
total composition
value
controlled release
Prior art date
Application number
ZA955153A
Other languages
English (en)
Inventor
S Esmail Tabibi
Robert W Mendes
Nithin P Pathak
Original Assignee
Ascent Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascent Pharma Inc filed Critical Ascent Pharma Inc
Publication of ZA955153B publication Critical patent/ZA955153B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
ZA955153A 1994-06-21 1995-06-21 Controlled release aqueous emulsion ZA955153B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26327794A 1994-06-21 1994-06-21
US08/491,626 US5672358A (en) 1994-06-21 1995-06-19 Controlled release aqueous emulsion

Publications (1)

Publication Number Publication Date
ZA955153B true ZA955153B (en) 1996-05-07

Family

ID=26949751

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955153A ZA955153B (en) 1994-06-21 1995-06-21 Controlled release aqueous emulsion

Country Status (11)

Country Link
US (1) US5672358A (de)
EP (1) EP0773780B1 (de)
JP (1) JP3583435B2 (de)
AT (1) ATE217186T1 (de)
AU (1) AU706516B2 (de)
CA (1) CA2193497C (de)
DE (1) DE69526655T2 (de)
DK (1) DK0773780T3 (de)
ES (1) ES2176333T3 (de)
WO (1) WO1995035096A1 (de)
ZA (1) ZA955153B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751222B1 (fr) * 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US7541020B2 (en) * 1997-05-08 2009-06-02 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
NZ515644A (en) * 1999-06-04 2004-12-24 Skyepharma Inc Oil-core compositions for the sustained release of hydrophobic drugs
US6703319B1 (en) 1999-06-17 2004-03-09 Micron Technology, Inc. Compositions and methods for removing etch residue
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
EP1305008A4 (de) * 2001-03-27 2005-02-09 R P Scherer Technologies Inc A Verbesserte formen von pharmazeutischen wirkstoffen und verfahren zu deren herstellung
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US20030139582A1 (en) * 2002-01-17 2003-07-24 Wang Kai Hua Composition containing biologically active polypeptides suitable for the oral administration
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
WO2004053056A2 (en) * 2002-09-24 2004-06-24 University Of Kentucky Research Foundation Nanoparticle-based vaccine delivery system containing adjuvant
CA2430541A1 (en) * 2003-05-30 2004-11-30 Isomers Laboratories Cosmetic
CN1893931B (zh) * 2003-10-27 2011-07-20 陶氏康宁公司 局部用制剂及将活性剂传递给基底的方法
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
JP2008531045A (ja) * 2005-03-04 2008-08-14 ディーエスエム アイピー アセッツ ビー．ブイ． 食品用微粒子状脂質組成物
KR101430767B1 (ko) 2005-07-18 2014-08-19 유니버시티 오브 메사츄세츠 로웰 나노에멀젼 조성물 및 이의 제조 및 사용 방법
US20080260816A1 (en) * 2005-09-16 2008-10-23 Bengt Herslof Particulate Lipid Pharmaceutical Composition
KR102110379B1 (ko) 2005-12-01 2020-05-14 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2649109A1 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
JP5292304B2 (ja) 2006-12-01 2013-09-18 アンテリオス， インコーポレイテッド ペプチドナノ粒子およびその使用
KR20150028856A (ko) 2007-05-31 2015-03-16 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
GB201006215D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20120015913A1 (en) * 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
AU2010359346B2 (en) * 2010-08-20 2015-01-29 Dr. Reddy's Laboratories Sa Phospholipid depot
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
EP3541358A1 (de) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermale verabreichung von grossen wirkstoffen
US11278493B2 (en) 2018-12-10 2022-03-22 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
ES2136620T3 (es) * 1991-04-19 1999-12-01 Lds Technologies Inc Formulaciones de microemulsiones convertibles.
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Also Published As

Publication number Publication date
ATE217186T1 (de) 2002-05-15
US5672358A (en) 1997-09-30
DE69526655T2 (de) 2002-12-05
JP2002510279A (ja) 2002-04-02
ES2176333T3 (es) 2002-12-01
CA2193497C (en) 2000-10-17
EP0773780A1 (de) 1997-05-21
EP0773780A4 (de) 1998-09-30
AU2907095A (en) 1996-01-15
DK0773780T3 (da) 2002-09-09
WO1995035096A1 (en) 1995-12-28
EP0773780B1 (de) 2002-05-08
DE69526655D1 (de) 2002-06-13
JP3583435B2 (ja) 2004-11-04
AU706516B2 (en) 1999-06-17
CA2193497A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
ZA955153B (en) Controlled release aqueous emulsion
EP0041772B1 (de) Fett-Emulsion, die ein Steroid enthält
US5250236A (en) Method for producing solid lipid microspheres having a narrow size distribution
CA2142103A1 (en) Submicron emulsions as ocular drug delivery vehicles
EP0702548B1 (de) Hautpflegezusammensetzung mit emulsioniertem petroleum
KR920017642A (ko) 고체 지질 입자의 현탁액을 함유한 국소제제
TW225987B (de)
EP0272374A3 (de) Bioaktive Zusammensetzungen und Verfahren zu deren Herstellung und Verwendung
UA27698C2 (uk) Спосіб одержання мікрокапсули поліпептиду
AU645108B2 (en) Prolonged release microcapsules
ZA9410149B (en) Composition
FR2767064B1 (fr) Procede de liberation d'un principe actif contenu dans une emulsion multiple
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
EP0279641A2 (de) Kosmetische Präparate
EP0626850A4 (de) Trockene zusammensetzung zur herstellung von emulsionen im submikron-bereich.
Jumaa et al. The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant
AU2968089A (en) Emulsion compositions including amphipathic emulsifying agents
TR199901716T2 (en) So�utucu ya�lama em�lsiyonu.
WO1996032923A3 (de) Antitranspirantien
Osborne et al. Role of stratum corneum lipids as moisture retaining agent
WO2001007058A3 (en) Parenteral cisplatin emulsion
JPH0987130A (ja) 乳化組成物
US5607622A (en) Oil-in-water cream base
ES2059827T3 (es) Emulsion para administracion parenteral.
ATE270869T1 (de) ZUSAMMENSETZUNG MIT KONTINUIERLICHER WÄSSERIGER PHASE, DIE L-2-OXOTHIAZOLIDIN- 4-CARBONSÄURE ENTHÄLTß.